Xiaofei Sun, Zijun Zhen, Zhuowei Liu and collaborators from the State Key Laboratory of Oncology in South China and Sun Yat-sen University Cancer Center, Guanghzou China have just published in Cancers the results from their clinical experience with metronomic maintenance in neuroblastoma entitled :Oral Metronomic Maintenance Therapy Can Improve Survival in High-Risk Neuroblastoma Patients Not Treated with ASCT or Anti-GD2 Antibodies
Abstract
Despite aggressive treatment, the prognosis (…)